![Australian housing sector faces risk amid deteriorating volume cycle - MS](https://i-invdn-com.investing.com/news/LYNXMPEDA104N_S.jpg)
Please try another search
Aspira Pathlab & Diagnostics Limited is an India-based company that is engaged in the business of running, owning, managing and administering diagnostics centers. The principal activities of the Company consist of pathology investigation services, radiology investigation services and other related healthcare services at diagnostic centers in Mumbai. The Company carries out pathological investigations in various branches, including biochemistry, hematology, histopathology, microbiology, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. The Company's tests include COVID-19 tests, health packages and pathology tests. Its COVID-19 tests include Shanti Screening Test, COVID-19 Antibody Test, COVID-19 Surveillance Profile, COVID-19 RT-PCR Test, COVID-19 Detection Profile 1 and COVID-19 Detection Profile 2.
Name | Age | Since | Title |
---|---|---|---|
Pankaj Jashwant Shah | - | 2016 | CEO, MD & Executive Director |
Haseeb Ahmad Drabu | 60 | 2018 | Independent Non-Executive Chairman of the Board |
Avinash Chander Mahajan | - | 2017 | Independent Non-Executive Director |
Mangala Radhakrishnan Prabhu | 67 | 2015 | Non-Executive Independent Director |
Nikunj Velji Mange | 32 | 2020 | Executive Director |
Manas Mengar | - | 2023 | Non-Executive & Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review